The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IIa study of aDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from breast cancer.
 
Shipra Gandhi
Honoraria - Aptitude Health; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Hologic/Biotheranostics; MedPage Today; Novartis; Peerview
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - MJH Life Sciences; Roche
 
Peter Forsyth
Honoraria - Anheart Therapeutics; BTG; EnClear Therapies; Florida Biomedical Research Program/Bankhead Coley (Inst); Mayo Clinic, Department of Neurology; Midatech Pharma; Stanford University Health, Department of Neurology
Consulting or Advisory Role - BTG; Daiichi Sankyo/Lilly; EnClear Therapies; Midatech Pharma; National Brain Tumor Society
Research Funding - Bankhead-Coley Cancer Research (Inst); Department of Defense (Inst); Florida Academic Cancer Center Alliance; Florida Breast Cancer Foundation; Melanoma Research Alliance; MSCCoE; NIH/NCI (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; BTG; National Cancer Research Institute (NCRI); NCI; NIH
 
Mateusz Opyrchal
Stock and Other Ownership Interests - crispr therapeutics
Consulting or Advisory Role - AstraZeneca
Research Funding - Alphageneron; Bayer; IDEAYA Biosciences; Immune-Onc Therapeutics; ImmuneOnco Biopharmaceuticals; Krystal Biotech; LaNova; Monte Rosa Therapeutics; Pfizer; PMV Pharma; Werewolf Therapeutics
 
Audrey Rawleigh
No Relationships to Disclose
 
Matthew Sydor
No Relationships to Disclose
 
Kamran Ahmed
Honoraria - Bristol-Myers Squibb; Cancer Network; Castle Biosciences
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst)
 
Kristopher Attwood
No Relationships to Disclose
 
Patrick Dillon
Research Funding - Daiichi Sankyo (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Tolero Pharmaceuticals (Inst)
 
Camilo Fadul
No Relationships to Disclose
 
Dheerendra Prasad
No Relationships to Disclose
 
Sheheryar Kabraji
No Relationships to Disclose
 
Ellis Levine
Patents, Royalties, Other Intellectual Property - UpToDate
 
Kevin Kalinsky
Employment - EQRx (I)
Stock and Other Ownership Interests - EQRx (I)
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Cullinan Oncology; Daiichi Sankyo/Astra Zeneca; eFFECTOR Therapeutics; Genentech/Roche; Gilead Sciences; Lilly; Menarini Silicon Biosystems; Merck; mersana; Mersana; Myovant Sciences; Novartis; Pfizer; Prelude Therapeutics; ProteinQure; Puma Biotechnology; RayzeBio; Regor; Relay Therapeutics; Takeda
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Daichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Seagen (Inst)
 
Brian Czerniecki
Patents, Royalties, Other Intellectual Property - Patent filed DC1 activation through Univesrity of Pennsylvania (Inst)
 
Pawel Kalinski
No Relationships to Disclose